| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | EPO (European Patent Office) | 6 | |
| #3 | Canada | 5 | |
| #4 | WIPO (World Intellectual Property Organization) | 3 | |
| #5 | Japan | 2 | |
| #6 | Brazil | 1 | |
| #7 | China | 1 | |
| #8 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology | |
| #3 | Organic fine chemistry | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Syringes | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Gonyer David A | 20 |
| #2 | D'Onofrio Matthew J | 15 |
| #3 | Carlson Marilyn R | 13 |
| #4 | Alves Wayne | 8 |
| #5 | Shah Shirish A | 7 |
| #6 | Madden Stuart J | 7 |
| #7 | D Onofrio Matthew J | 5 |
| #8 | David A Gonyer | 4 |
| #9 | Marilyn R Carlson | 4 |
| #10 | Matthew J D'Onofrio | 3 |
| Publication | Filing date | Title |
|---|---|---|
| US2020276139A1 | Methods of intranasal metoclopramide dosing | |
| US2019388370A1 | Treatment of symptoms associated with female gastroparesis | |
| EP3554489A1 | Treatment of moderate and severe gastroparesis | |
| US2013213393A1 | Nasal formulations of metoclopramide | |
| EP2747561A1 | Treatment of symptoms associated with female gastroparesis | |
| CA2780485A1 | Nasal formulations of metoclopramide |